Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions	3 Months Ended
	Jul. 29, 2022	Jul. 30, 2021
Income Statement [Abstract]
Net sales	$ 7,371,000,000	$ 7,987,000,000
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	2,516,000,000	2,598,000,000
Research and development expense	692,000,000	750,000,000
Selling, general, and administrative expense	2,567,000,000	2,547,000,000
Amortization of intangible assets	423,000,000	436,000,000
Restructuring charges, net	14,000,000	11,000,000
Certain litigation charges, net	0	26,000,000
Other operating expense, net	35,000,000	760,000,000
Operating profit	1,125,000,000	859,000,000
Other non-operating income, net	(83,000,000)	(111,000,000)
Interest expense	164,000,000	137,000,000
Income before income taxes	1,044,000,000	833,000,000
Income tax provision	112,000,000	64,000,000
Net income	931,000,000	769,000,000
Net income attributable to noncontrolling interests	(2,000,000)	(6,000,000)
Net income attributable to Medtronic	$ 929,000,000	$ 763,000,000
Basic earnings per share (usd per share)	$ 0.70	$ 0.57
Diluted earnings per share (usd per share)	$ 0.70	$ 0.56
Basic weighted average shares outstanding (shares)	1,329.4	1,344.5
Diluted weighted average shares outstanding (shares)	1,334.5	1,356.4